Table 1.
IL‐1ß secretion levels in melanoma cell lines. Summary of the reported values of IL‐1ß secretion of melanoma cell lines measured by ELISA. Some of the values shown are approximated based on the original data.
Cell line | IL1B (pg·mL−1) | Type | References | Cell line | IL1B (pg·mL−1) | Type | References |
---|---|---|---|---|---|---|---|
1205Lu | > 50 | Cutaneous | Okamoto, 2010 [30] | MA2058 | 0 | Cutaneous | Gehrke, 2014 [31] |
1205Lu | 120 | Cutaneous | Liu, 2013 [32] | Memel 82 | 0 | Cutaneous | Gehrke, 2014 [31] |
1205Lu | 120 | Cutaneous | Ellis, 2011 [33] | MeWo | 0.15–0.2 | Cutaneous | Rovera, 2022 [34] |
1205Lu | 0.1–0.15 | Cutaneous | Rovera, 2022 [34] | MM001 | 0.15–0.2 | Cutaneous | Rovera, 2022 [34] |
1205lu | 300–400 | Cutaneous | Tengesdal, 2021 [23] | MM029 | 0 | Cutaneous | Rovera, 2022 [34] |
1205Lu | 600–800 | Cutaneous | Tengesdal, 2021 [24] | MM074 | 0.15–0.2 | Cutaneous | Rovera, 2022 [34] |
501Mel | 0 | Cutaneous | Young, 2017 [35] | MM099 | 0.15–0.2 | Cutaneous | Rovera, 2022 [34] |
501Mel | 0.15–0.2 | Cutaneous | Rovera, 2022 [34] | MM485 | 0 | Cutaneous | Young, 2017 [35] |
888mel | 0 | Cutaneous | Young, 2017 [35] | MNC1 | 0.05–0.1 | Cutaneous | Rovera, 2022 [34] |
A357 a | 10–15 | Cutaneous | Tengesdal, 2021 [24] | MUM2B | 75–100 | Uveal | Triozzi, 2011 [36] |
A375 | 9 | Cutaneous | Okamoto, 2010 [30] | MV3 | 0 | Cutaneous | Young, 2017 [35] |
A375 | 0 | Cutaneous | Gehrke, 2014 [31] | OCM1 | 0–25 | Uveal | Triozzi, 2011 [36] |
A375 | 0 | Cutaneous | Young, 2017 [35] | SBCI2 | < 0.05 | Cutaneous | Rovera, 2022 [34] |
DO4 | 0 | Cutaneous | Young, 2017 [35] | SK‐MEL28 | 0.15–0.2 | Cutaneous | Rovera, 2022 [34] |
EB16Mel | 2050 | Cutaneous | Kholmanskikh, 2010 [37] | WM115 | < 2 | Cutaneous | Okamoto, 2010 [30] |
HS294T | 20 | Cutaneous | Okamoto, 2010 [30] | WM115 | 0 | Cutaneous | Liu, 2013 [32] |
Hs294t | 80 | Cutaneous | Liu, 2013 [32] | WM1361 | 0 | Cutaneous | Young, 2017 [35] |
Hs294T | 25–30 | Cutaneous | Ellis, 2011 [33] | WM1552C | < 2 | Cutaneous | Okamoto, 2010 [30] |
Kul84‐Mel | < 3 | Cutaneous | Kholmanskikh, 2010 [37] | WM164 | 0.15–0.2 | Cutaneous | Rovera, 2022 [34] |
LB2259‐Mel | < 3 | Cutaneous | Kholmanskikh, 2010 [37] | WM164 | 0 | Cutaneous | Young, 2017 [35] |
LB2439‐Mel | < 3 | Cutaneous | Kholmanskikh, 2010 [37] | WM2032 | < 0.05 | Cutaneous | Rovera, 2022 [34] |
M000 291 | 0 | Cutaneous | Gehrke, 2014 [31] | WM266‐4 | 25–30 | Cutaneous | Serini, 2020 [38] |
M010 119 | 0 | Cutaneous | Gehrke, 2014 [31] | WM266‐4 | 0 | Cutaneous | Young, 2017 [35] |
M010 817 | 0 | Cutaneous | Gehrke, 2014 [31] | WM278 | < 2 | Cutaneous | Okamoto, 2010 [30] |
M060 125 | 0 | Cutaneous | Gehrke, 2014 [31] | WM35 | < 2 | Cutaneous | Okamoto, 2010 [30] |
M080 228 | 0 | Cutaneous | Gehrke, 2014 [31] | WM35 | 0 | Cutaneous | Liu, 2013 [32] |
M080 306 | 0 | Cutaneous | Gehrke, 2014 [31] | WM75 | < 2 | Cutaneous | Okamoto, 2010 [30] |
M080 904 | 0 | Cutaneous | Gehrke, 2014 [31] | WM793 | < 0.05 | Cutaneous | Rovera, 2022 [34] |
M081 021 | 0 | Cutaneous | Gehrke, 2014 [31] | WM793B | 44 | Cutaneous | Okamoto, 2010 [30] |
M081028 | 0 | Cutaneous | Gehrke, 2014 [31] | WM852 | 0 | Cutaneous | Young, 2017 [35] |
Likely a typing mistake on the original paper, probably referring to the cell line A375.